Restriction in competitive sports is recommended in the presence of moderate left ventricular (LV) enlargement or dysfunction, uncontrolled tachyarrhythmias, long QT interval, unexplained syncope, prior resuscitation from cardiac arrest, or aortic root enlargement.[48]Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities – general considerations. J Am Coll Cardiol. 2005 Apr 19;45(8):1318-21.
http://www.ncbi.nlm.nih.gov/pubmed/15837280?tool=bestpractice.com
[49]Maron BJ, Ackerman MJ, Nishimura RA, et al. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol. 2005 Apr 19;45(8):1340-5.
https://www.sciencedirect.com/science/article/pii/S0735109705002779?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/15837284?tool=bestpractice.com
Patients with increased adrenergic response to stress or activity demonstrated on event monitoring may benefit from lifestyle changes such as reducing alcohol, reducing stimulants such as coffee and colas, and engaging in a consistent exercise program. Athletes with MVP and ventricular arrhythmias exhibited larger LV and left atrial dimensions, along with comparable LV systolic function, and a higher occurrence of MAD (16% vs. 3%; P <0.001) when compared to athletes with MVP but no ventricular arrhythmias.[26]Van der Bijl P, Stassen J, Haugaa KH, et al. Mitral annular disjunction in the context of mitral valve prolapse: identifying the at-risk patient. JACC Cardiovasc Imaging. 2024 Apr 18:S1936-878X(24)00119-0.
https://www.sciencedirect.com/science/article/pii/S1936878X24001190?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/38703174?tool=bestpractice.com